Business Today
Loading...

USFDA allows Zydus Cadila to sell generic drug for treating headaches

The company has received final approval from the United States Food and Drug Administration (USFDA) to market Butalbital, Acetaminophen and Caffeine tabletsin strengths of 50mg/325mg/40 mg, Zydus Cadila said in a statement

twitter-logoPTI | July 18, 2020 | Updated 17:01 IST
USFDA allows Zydus Cadila to sell generic drug for treating headaches

Drug firm Zydus Cadila on Saturday said it has received final approval from the US health regulator to market generic Butalbital, Acetaminophen and Caffeine combination tablets to treat symptoms of tension headaches.

The company has received final approval from the United States Food and Drug Administration (USFDA) to market Butalbital, Acetaminophen and Caffeine tabletsin strengths of 50mg/325mg/40 mg, Zydus Cadila said in a statement.

The drug will be manufactured at Nesher Pharma's manufacturing facility at St. Louis in the US, it added.

This combination medication is used to treat symptom complex of tension (or muscle contraction) headaches, Zydus Cadila said.

Thegroup now has 294 approvals and has filed over 390 abbreviated new drug applications (ANDAs) since the commencement of the filing process, it added.Also Read: Air India calls financial situation challenging, leave without pay 'win-win situation' Also Read: Informed PM Modi of coronavirus crisis in Maharashtra: Former CM Devendra Fadnavis

Youtube
  • Print

  • COMMENT
BT-Story-Page-B.gif
A    A   A
close